Relationship of Type 1 Cannabinoid Receptor Availability in the Human Brain to Novelty-Seeking Temperament

被引:46
|
作者
Van Laere, Koen [1 ,2 ]
Goffin, Karolien [2 ]
Bormans, Guy [3 ]
Casteels, Cindy [2 ]
Mortelmans, Luc [2 ]
de Hoon, Jan [1 ]
Grachev, Igor [5 ]
Vandenbulcke, Mathieu [4 ]
Pieters, Guido [4 ]
机构
[1] Univ Hosp Leuven, Ctr Clin Pharmacol, Louvain, Belgium
[2] Katholieke Univ Leuven, Div Nucl Med, Louvain, Belgium
[3] Katholieke Univ Leuven, Lab Radiopharm, Louvain, Belgium
[4] Katholieke Univ Leuven, Dept Psychiat, Louvain, Belgium
[5] Merck Inc, Imaging Res Labs, West Point, PA USA
关键词
POSITRON-EMISSION-TOMOGRAPHY; ENDOCANNABINOID SYSTEM; PERSONALITY-TRAITS; HEALTHY-SUBJECTS; OVERWEIGHT PATIENTS; PARKINSONS-DISEASE; BASAL GANGLIA; RISK-FACTORS; DRUG-ABUSE; BINDING;
D O I
10.1001/archgenpsychiatry.2008.530
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Context: Brain neurochemistry can partially account for personality traits as a variance of normal human behavior, as has been demonstrated for monoamine neurotransmission. Positron emission tomography using fluorine 18-labeled MK-9470 now enables quantification of type 1 cannabinoid receptors (CB1R) in the brain. Objective: To investigate whether there is a relationship between human temperament traits and regional cerebral CB1R availability. Design: Forty-seven [(18)F] MK-9470 baseline scanning sessions were performed and correlated with the temperament dimensions and subdimensions of the 240-item Cloninger Temperament and Character Inventory. Setting: Academic brain imaging center. Participants: Forty-seven nonsmoking, healthy volunteers (paid). Main Outcome Measure: Voxel-based correlation of temperament variables of the inventory with regional CB1R availability. Results: Novelty seeking was inversely correlated with global CB1R availability (r=-0.33, P=.02), with the most significant correlation in the left amygdala (r=-0.41, P=.005). In particular, the subdimension extravagance showed a highly significant inverse correlation to global CB1R availability (r=- 0.53, P <.001), most pronounced in the amygdala, anterior cingulate, parietal cortex, and precuneus. Also, disorderliness was inversely correlated with global CB1R availability ( r=-0.31, P=.04). Conclusions: Low baseline cerebral CB1R availability is related to a high novelty-seeking personality, in particular to extravagance, mostpronouncedin the amygdala. Further investigation of the functional role of the CB1R is warranted in pathological behavior known to be strongly related to novelty seeking, such as addiction and eating disorders.
引用
收藏
页码:196 / 204
页数:9
相关论文
共 50 条
  • [21] Preclinical evaluation and quantification of [18F]MK-9470 as a radioligand for PET imaging of the type 1 cannabinoid receptor in rat brain
    Casteels, Cindy
    Koole, Michel
    Celen, Sofie
    Bormans, Guy
    Van Laere, Koen
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 (09) : 1467 - 1477
  • [22] Type 1 cannabinoid receptor mapping with [18F]MK-9470 PET in the rat brain after quinolinic acid lesion: a comparison to dopamine receptors and glucose metabolism
    Casteels, Cindy
    Martinez, Emili
    Bormans, Guy
    Camon, Lluisa
    de Vera, Nuria
    Baekelandt, Veerle
    Planas, Anna M.
    Van Laere, Koen
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (12) : 2354 - 2363
  • [23] Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study
    Neumeister, A.
    Normandin, M. D.
    Pietrzak, R. H.
    Piomelli, D.
    Zheng, M. Q.
    Gujarro-Anton, A.
    Potenza, M. N.
    Bailey, C. R.
    Lin, S. F.
    Najafzadeh, S.
    Ropchan, J.
    Henry, S.
    Corsi-Travali, S.
    Carson, R. E.
    Huang, Y.
    MOLECULAR PSYCHIATRY, 2013, 18 (09) : 1034 - 1040
  • [24] Cannabinoid Receptor Type 1 in the Brain Regulates the Affective Component of Visceral Pain in Mice
    Bajic, Danica
    Monory, Krisztina
    Conrad, Andrea
    Maul, Christina
    Schmid, Roland M.
    Wotjak, Carsten T.
    Stein-Thoeringer, Christoph K.
    NEUROSCIENCE, 2018, 384 : 397 - 405
  • [25] A positive relationship between harm avoidance and brain nicotinic acetylcholine receptor availability
    Storage, Steven
    Mandelkern, Mark A.
    Phuong, Jonathan
    Kozman, Maggie
    Neary, Meaghan K.
    Brody, Arthur L.
    PSYCHIATRY RESEARCH-NEUROIMAGING, 2013, 214 (03) : 415 - 421
  • [26] Test-retest reproducibility of cannabinoid-receptor type 1 availability quantified with the PET ligand [11C]MePPEP
    Barros, Daniela A. Riano
    McGinnity, Colm J.
    Rosso, Lula
    Heckemann, Rolf A.
    Howes, Oliver D.
    Brooks, David J.
    Duncan, John S.
    Turkheimer, Federico E.
    Koepp, Matthias J.
    Hammers, Alexander
    NEUROIMAGE, 2014, 97 : 151 - 162
  • [27] In vivo correlation of serotonin transporter and 1B receptor availability in the human brain: a PET study
    Svensson, Jonas E.
    Tiger, Mikael
    Plaven-Sigray, Pontus
    Halldin, Christer
    Schain, Martin
    Lundberg, Johan
    NEUROPSYCHOPHARMACOLOGY, 2022, 47 (10) : 1863 - 1868
  • [28] Cannabinoid receptor type 1 immunoreactivity and disease severity in human epithelial ovarian tumors
    Messalli, Enrico Michelino
    Grauso, Flavio
    Luise, Rossella
    Angelini, Anna
    Rossiello, Raffaele
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2014, 211 (03) : 234.e1 - 234.e6
  • [29] RETRACTED: Cannabinoid Type 1 Receptor Availability in the Amygdala Mediates Threat Processing in Trauma Survivors (Retracted Article)
    Pietrzak, Robert H.
    Huang, Yiyun
    Corsi-Travali, Stefani
    Zheng, Ming-Qiang
    Lin, Shu-fei
    Henry, Shannan
    Potenza, Marc N.
    Piomelli, Daniele
    Carson, Richard E.
    Neumeister, Alexander
    NEUROPSYCHOPHARMACOLOGY, 2014, 39 (11) : 2519 - 2528
  • [30] A PET study comparing receptor occupancy by five selective cannabinoid 1 receptor antagonists in non-human primates
    Hjorth, Stephan
    Karlsson, Cecilia
    Jucaite, Aurelija
    Varnas, Katarina
    Hamren, Ulrika Wahlby
    Johnstrom, Peter
    Gulyas, Balazs
    Donohue, Sean R.
    Pike, Victor W.
    Halldin, Christer
    Farde, Lars
    NEUROPHARMACOLOGY, 2016, 101 : 519 - 530